In a drive to improve the care of patients suffering from long-term illnesses, NHS Scotland has embarked on an innovative research project with partners Trustmarque and KenSci, to create a trial risk prediction platform which aims to help predict pulmonary risk and improve care for patients suffering from chronic obstructive pulmonary disease (COPD).

Dragonfly AI is one of six companies in the Capita Scaling Partner portfolio, having joined in August 2019. Today they release what has already proven, in beta, to be an invaluable tool for designers, creatives, and publishers of digital content.

DragonflyAI, the British predictive analytics platform which is backed by Capita, is delighted to announce today the completion of a £625,000 ($1m) seed funding round.

Capita plc (Capita) today announces its Local Public Services (LPS) business has secured an extension worth £27.1m over three years to its current contract with Central London Community Healthcare NHS Trust (CLCH).

CHKS has been awarded a new contract for the provision of an all Wales national and Health Board clinical benchmarking and analytics system.